<VariationArchive VariationID="463736" VariationName="NM_004360.5(CDH1):c.1948_1949dup (p.Ile651fs)" VariationType="Duplication" Accession="VCV000463736" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2017-12-26" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="466908" VariationID="463736">
      <GeneList>
        <Gene Symbol="CDH1" FullName="cadherin 1" GeneID="999" HGNC_ID="HGNC:1748" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="68737292" stop="68835537" display_start="68737292" display_stop="68835537" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="68771194" stop="68869443" display_start="68771194" display_stop="68869443" Strand="+" />
          </Location>
          <OMIM>192090</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDH1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004360.5(CDH1):c.1948_1949dup (p.Ile651fs)</Name>
      <CanonicalSPDI>NC_000016.10:68823408:TAT:TATAT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="68823408" stop="68823409" display_start="68823408" display_stop="68823409" variantLength="2" positionVCF="68823408" referenceAlleleVCF="C" alternateAlleleVCF="CTA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="68857311" stop="68857312" display_start="68857311" display_stop="68857312" variantLength="2" positionVCF="68857311" referenceAlleleVCF="C" alternateAlleleVCF="CTA" />
      </Location>
      <OtherNameList>
        <Name>NM_004360.5(CDH1):c.1948_1949dup</Name>
        <Name>p.Ile651fs</Name>
      </OtherNameList>
      <ProteinChange>I135fs</ProteinChange>
      <ProteinChange>I651fs</ProteinChange>
      <ProteinChange>I590fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_301" sequenceAccession="LRG_301" change="g.91119_91120dup">
            <Expression>LRG_301:g.91119_91120dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_301t1" sequenceAccession="LRG_301t1" change="c.1948_1949dup">
            <Expression>LRG_301t1:c.1948_1949dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001317184.2" sequenceAccession="NM_001317184" sequenceVersion="2" change="c.1765_1766dup">
            <Expression>NM_001317184.2:c.1765_1766dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001304113.1" sequenceAccession="NP_001304113" sequenceVersion="1" change="p.Ile590fs">
            <Expression>NP_001304113.1:p.Ile590fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001317185.2" sequenceAccession="NM_001317185" sequenceVersion="2" change="c.400_401dup">
            <Expression>NM_001317185.2:c.400_401dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001304114.1" sequenceAccession="NP_001304114" sequenceVersion="1" change="p.Ile135fs">
            <Expression>NP_001304114.1:p.Ile135fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001317186.2" sequenceAccession="NM_001317186" sequenceVersion="2" change="c.-18_-17dup">
            <Expression>NM_001317186.2:c.-18_-17dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004360.5" sequenceAccession="NM_004360" sequenceVersion="5" change="c.1948_1949dup" MANESelect="true">
            <Expression>NM_004360.5:c.1948_1949dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004351.1" sequenceAccession="NP_004351" sequenceVersion="1" change="p.Ile651fs">
            <Expression>NP_004351.1:p.Ile651fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.68823410_68823411dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.68823410_68823411dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.68857313_68857314dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.68857313_68857314dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008021.1" sequenceAccession="NG_008021" sequenceVersion="1" change="g.91119_91120dup">
            <Expression>NG_008021.1:g.91119_91120dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004360.3" sequenceAccession="NM_004360" sequenceVersion="3" change="c.1948_1949dupAT">
            <Expression>NM_004360.3:c.1948_1949dupAT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658658494" DB="ClinGen" />
        <XRef Type="rs" ID="1555517074" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004360.5(CDH1):c.1948_1949dup (p.Ile651fs) AND Hereditary diffuse gastric adenocarcinoma" Accession="RCV000551453" Version="5">
        <ClassifiedConditionList TraitSetID="3314">
          <ClassifiedCondition DB="MedGen" ID="C1708349">Hereditary diffuse gastric adenocarcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004360.5(CDH1):c.1948_1949dup (p.Ile651fs) AND CDH1-related diffuse gastric and lobular breast cancer syndrome" Accession="RCV003328395" Version="2">
        <ClassifiedConditionList TraitSetID="86761">
          <ClassifiedCondition DB="MedGen" ID="CN311521">CDH1-related diffuse gastric and lobular breast cancer syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2023-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-04" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-12-26" MostRecentSubmission="2024-02-20">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15235021</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20373070</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/dd913191-6c79-4d17-b22a-8408e8604111</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="3314" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1360" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary diffuse gastric adenocarcinoma</ElementValue>
                <XRef ID="MONDO:0007648" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary diffuse gastric cancer</ElementValue>
                <XRef ID="Hereditary+diffuse+gastric+cancer/8514" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HDGC</ElementValue>
                <XRef Type="MIM" ID="137215" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant susceptibility for diffuse gastric cancer, a poorly differentiated adenocarcinoma that infiltrates into the stomach wall causing thickening of the wall (linitis plastica) without forming a distinct mass. Diffuse gastric cancer is also referred to as signet ring carcinoma or isolated cell-type carcinoma. The average age of onset of HDGC is 38 years (range: 14-69 years). The majority of the cancers in individuals with a CDH1 pathogenic variant occur before age 40 years. The estimated cumulative risk of gastric cancer by age 80 years is 70% for men and 56% for women. Women are also at a 42% risk for lobular breast cancer.</Attribute>
                <XRef ID="NBK1139" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10900" />
                <XRef ID="10900" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301318</ID>
                <ID Source="BookShelf">NBK1139</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACS, 2007">
                <ID Source="PubMed">17392385</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="IGCLC, 2010">
                <ID Source="pmc">2991043</ID>
              </Citation>
              <Citation Type="general" Abbrev="Klujit et al., 2012">
                <ID Source="PubMed">22388873</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="IGCLC, 2020">
                <ID Source="PubMed">32758476</ID>
                <ID Source="pmc">7116190</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Gastric Cancer, 2023</CitationText>
              </Citation>
              <XRef ID="26106" DB="Orphanet" />
              <XRef ID="C1708349" DB="MedGen" />
              <XRef ID="MONDO:0007648" DB="MONDO" />
              <XRef Type="MIM" ID="137215" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="86761" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="62276" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CDH1-related diffuse gastric and lobular breast cancer</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CDH1-related diffuse gastric and lobular breast cancer syndrome</ElementValue>
                <XRef ID="MONDO:0100488" DB="MONDO" />
              </Name>
              <XRef ID="CN311521" DB="MedGen" />
              <XRef ID="MONDO:0100488" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="3816630" SubmissionDate="2023-09-13" DateLastUpdated="2023-09-20" DateCreated="2021-09-29">
        <ClinVarSubmissionID localKey="dd913191-6c79-4d17-b22a-8408e8604111" localKeyIsSubmitted="1" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001943351" DateUpdated="2023-09-20" DateCreated="2021-09-29" Type="SCV" Version="2" SubmitterName="ClinGen CDH1 Variant Curation Expert Panel" OrgID="506817" OrganizationCategory="consortium" OrgAbbreviation="CDH1 EP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-04">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/dd913191-6c79-4d17-b22a-8408e8604111</URL>
          </Citation>
          <Comment>The c.1948_1949dup p.(Ile651fs) variant is predicted to result in a premature stop codon that leads to nonsense mediate decay (PVS1 and PM5_supporting). The variant is absent in the gnomAD cohort (PM2_supporting; http://gnomad.broadinstitute.org). Therefore, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria applied as specified by the CDH1 Variant Curation Expert Panel (CDH1 VCEP specifications version 3.1): PVS1, PM2_supporting, PM5_supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen CDH1 ACMG Specifications V3.1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/zeannmug/clingen_cdh1_acmg_specifications_v3.1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_004360.5(CDH1):c.1948_1949dup</Name>
            <Name>p.Ile651fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.10:g.68823410_68823411dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100488" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10433466</SubmissionName>
          <SubmissionName>SUB13838303</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1230261" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1768235|MedGen:C1708349" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000637760" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15235021</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20373070</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, loss-of-function variants in CDH1 are known to be pathogenic (PMID: 15235021, 20373070). This sequence change inserts 2 nucleotide in exon 13 of the CDH1 mRNA (c.1948_1949dupAT), causing a frameshift at codon 651. This creates a premature translational stop signal (p.Ile651Serfs*3) and is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.68857311_68857312insTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1708349" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1230261" TraitType="Disease" MappingType="XRef" MappingValue="C1708349" MappingRef="MedGen">
        <MedGen CUI="C1708349" Name="Hereditary diffuse gastric adenocarcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3816630" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100488" MappingRef="MONDO">
        <MedGen CUI="CN311521" Name="CDH1-related diffuse gastric and lobular breast cancer syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

